loadpatents
Patent applications and USPTO patent grants for Janssen; Daniel.The latest application filed is for "polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor".
Patent | Date |
---|---|
Cysteine linked nanobody dimers Grant 11,426,468 - Janssen , et al. August 30, 2 | 2022-08-30 |
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Glypican-3 And T Cell Receptor App 20220213215 - Janssen; Daniel ;   et al. | 2022-07-07 |
KV1.3 binding immunoglobulins Grant 11,149,086 - Van Hoorick , et al. October 19, 2 | 2021-10-19 |
Nanobody dimers linked via C-terminally engineered cysteins Grant 11,021,544 - Boutton , et al. June 1, 2 | 2021-06-01 |
Nanobody Dimers Linked Via C-terminally Engineered Cysteins App 20190100599 - Boutton; Carlo ;   et al. | 2019-04-04 |
Cysteine Linked Nanobody Dimers App 20170360955 - Janssen; Daniel ;   et al. | 2017-12-21 |
Kv1.3 Binding Immunoglobulins App 20170137512 - Van Hoorick; Diane ;   et al. | 2017-05-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.